Actaea Spicata Root Aloe Copper Cupric Arsenite Fr
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
- Actaea Spicata Root Aloe Copper Cupric Arsenite Fr
- ACTAEA SPICATA ROOT / ALOE / COPPER / ZINC (Multi-Component Formula): Insufficient Data for Repurposing Evaluation
ACTAEA SPICATA ROOT / ALOE / COPPER / ZINC (Multi-Component Formula): Insufficient Data for Repurposing Evaluation
One-Sentence Summary
This candidate is a multi-component combination product containing 10 ingredients—including botanical extracts, mineral compounds, and biological materials—consistent with a homeopathic or complex herbal formulation. The TxGNN model returned no predicted indications for this candidate, and no regulatory approvals, original indications, or safety records were identified in available databases. As a result, no evidence-based repurposing evaluation can be completed at this time.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not identified |
| Predicted New Indication | None (TxGNN returned no predictions) |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 — Model prediction only; in this case, no prediction was generated |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | Hold |
Why No Prediction Was Generated
The queried drug string comprises 10 distinct ingredients:
- Botanical extracts: Actaea spicata root, Aloe, Fraxinus americana bark, Solanum dulcamara top, Urtica urens
- Mineral/inorganic compounds: Copper, Cupric arsenite, Zinc
- Biological material: Skim milk
- Animal-derived: Lytta vesicatoria (cantharidin-containing Spanish fly)
This combination is characteristic of a homeopathic compound formulation. TxGNN operates on single active pharmaceutical ingredients (APIs) mapped to DrugBank IDs via the knowledge graph. Because:
- No DrugBank ID could be assigned to this multi-ingredient string
- No individual ingredient was resolved as the primary active compound
- No original indication was available to anchor the repurposing search
…the model could not generate any disease predictions. This is a pipeline input issue, not a signal that the formula lacks biological activity.
Conclusion and Next Steps
Decision: Hold
Rationale: This candidate cannot be evaluated for repurposing because the TxGNN pipeline requires a single mappable API with a DrugBank identifier. The submitted drug string describes a multi-component (likely homeopathic) formulation that is not supported by the current pipeline architecture.
To proceed, the following is needed:
- Decompose the formulation: Identify the single API or primary active ingredient intended for repurposing evaluation; submit each ingredient as a separate candidate if appropriate
- Confirm product category: Verify whether this product is registered as a homeopathic medicine, dietary supplement, or conventional drug in any jurisdiction—this determines which regulatory pathway and evidence standard applies
- Resolve DrugBank mapping: At minimum, Aloe vera, Zinc, or Copper may have individual DrugBank entries that could be queried separately
- Clarify clinical intent: Determine which ingredient (if any) is the therapeutic target for the new indication being explored
- Obtain safety documentation: Cupric arsenite is an arsenic-containing compound; TFDA package insert or equivalent regulatory safety data must be obtained before any clinical evaluation proceeds
- Re-submit as individual APIs: Once decomposed, each mappable ingredient should be run through the TxGNN pipeline independently
⚠️ Note: Cupric arsenite (copper(II) arsenite) contains inorganic arsenic. Any downstream clinical repurposing study involving this ingredient will require enhanced toxicological review and regulatory pre-consultation regardless of TxGNN prediction outcomes.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.